CAMBRIDGE, UK – Nuclera, a biotech company developing cutting-edge benchtop protein printing technologies, today announced that the first close of its Series B financing has raised $42.5 million. The funds raised will be used to accelerate the development and commercialization of its eProtein™ desktop bioprinter. Nuclera’s ground-breaking protein printing technology has attracted many new and existing institutional […]

GMP-compliant test for transduction efficiency marks a key milestone for Tapestri’s ability to power single-cell analysis in clinical trial settings for cell & gene therapies SOUTH SAN FRANCISCO — Mission Bio, the pioneer in high-throughput single-cell DNA and multi-omics analysis, announced today the first tech transfer of a clinical trial-ready cell and gene therapy (CGT) assay […]

BOSTON — NanoMosaic Inc., the pioneer and leader in nanoneedle (MosaicNeedle™) technology detection for proteomics, genomics, and single-run experiment multi-omics applications, has announced that it has officially opened its “Proteomics/Multi-Omics Early Access Program,” to life science researchers and to CLIA certified labs developing diagnostic applications. The Company is making a limited number of systems available […]

Key appointment will support the company’s commercial growth plans to deliver proteomics and protein innovations worldwide BURLINGAME, Calif. — Vector Laboratories, the pioneer of innovative proteomic and glycomic solutions, today announced the addition of Katy Miles to its Board of Directors, effective as of February 1, 2022. She joins recent addition David Smoller, General Partner […]

Abcam to license in VHH phage library(1) from Twist, complementing in-house recombinant antibody capabilities Abcam to develop and commercialize antibodies for diagnostic and research use, with Twist retaining rights for therapeutic applications Reinforces Abcam’s commitment to consistently improve industry standards and support the sector with best-in-class reagents CAMBRIDGE, England & SOUTH SAN FRANCISCO, Calif. — Twist Bioscience Corporation (NASDAQ:TWST), […]

Cytognos divestment is a first strategic step aimed at positioning Vitro as a new worldwide diagnostic player in their key market segments SEVILLE, Spain — Vitro S.A, (www.vitro.bio) a privately held company headquartered in Seville, Spain, announced today the sale of Cytognos to Becton Dickinson and Company (BD). Cytognos is a company specializing in flow cytometry solutions for blood […]

BOSTON, LAUSANNE, BORDEAUX, and MARSEILLE – SOPHiA GENETICS (Nasdaq: SOPH), a leader in Data-Driven Medicine, have announced, in conjunction with Assises de Génétique, an extension of their partnership with Institut Paoli Calmettes (IPC), one of the 18 French Comprehensive Cancer Centers (CLCC), to further support the implementation, automatization, and accreditation of solid tumor tests, to include […]

LEXINGTON, Ky. — NEOGEN Corporation (NASDAQ: NEOG) announced today that it has added a new chemiluminescent substrate as part of the trusted K-Blue® product line. K-Blue Luminescent is a two-component, luminol-based substrate that offers high sensitivity, ranging from the nanogram down to the femtogram level. This new formula is optimized to emit maximum light at […]

Biotech company recognized for culture supporting work-life balance Madison, WI USA. — Promega Corporation was recognized today as a top place to work in the US with a 2022 Top Workplaces USA award. Companies earn a place on the Top Workplaces USA list based solely on employee engagement surveys compiled by research firm Energage. More […]

Polyplus today announces the acquisition of E-Zyvec with a focus on expanding process economics optimization efforts for cell and gene therapy developers and manufacturers. Strasbourg, France – Polyplus, a leading provider of upstream process solutions for advanced biologic and cell and gene therapy production from research to commercial grade, today announces the acquisition of e-Zyvec, […]